# Vitamin K Bone Health Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/vitamin-k-bone-health-meta-analysis-evidence-review
Category: evidence-review
Summary: Vitamin K Bone Health Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sys
Last reviewed: 2026-05-19
Reviewed by: Migaku Evidence Review
# Vitamin K Bone Health Meta-analysis: What the Evidence Says

## Quick Answer

Vitamin K Bone Health Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Association Between VKORC1 Gene Polymorphisms and Osteopenia and Osteoporosis: A Systematic Review and Meta-Analysis | systematic review | 1 | 2026-01-15 | 10.3390/medicina62010180 |
| Vitamin K as an Endocrine Modulator: Mechanistic Links to Glucose Metabolism and Beyond | narrative review | 3 | 2026-04-09 | 10.3390/nu18081183 |

## What The Sources Report

- It is characterized by low bone mass and microarchitectural deterioration of bone matrix, resulting in increased bone fragility and fracture risk, impacting more frequently postmenopausal women and the elderly population. [Vesa Ştefan Cristian (2026); evidence level 1]
- Carboxylated OC binds hydroxyapatite crystals and contributes to bone strength and mineralization, while undercarboxylated OC, associated with vitamin K deficiency or impaired recycling, is linked to reduced BMD and increased fracture risk. [Vesa Ştefan Cristian (2026); evidence level 1]
- Accumulating evidence links this condition to impaired glucose and calcium metabolism, highlighting the need to better define VK's roles within the endocrine regulatory pathways. [Matuszewski Wojciech (2026); evidence level 3]
- In this narrative review, we integrate the current evidence on VK within the context of the endocrine system, with primary emphasis on glucose metabolism. [Matuszewski Wojciech (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin K bone health meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Vesa Ştefan Cristian (2026). Association Between VKORC1 Gene Polymorphisms and Osteopenia and Osteoporosis: A Systematic Review and Meta-Analysis. DOI: 10.3390/medicina62010180. PMCID: PMC12843655. PMID: 41597466. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12843655/
- Matuszewski Wojciech (2026). Vitamin K as an Endocrine Modulator: Mechanistic Links to Glucose Metabolism and Beyond. DOI: 10.3390/nu18081183. PMCID: PMC13118554. PMID: 42074997. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13118554/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.